z-logo
open-access-imgOpen Access
New Drugs and Regimens for Tuberculosis Disease Treatment in Children and Adolescents
Author(s) -
Anthony J. GarciaPrats,
Jeffrey R. Starke,
Brenda Waning,
Brian Kaiser,
James A. Seddon
Publication year - 2022
Publication title -
journal of the pediatric infectious diseases society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.269
H-Index - 31
eISSN - 2048-7207
pISSN - 2048-7193
DOI - 10.1093/jpids/piac047
Subject(s) - medicine , bedaquiline , clofazimine , rifapentine , tuberculosis , rifampicin , regimen , drug , adverse effect , intensive care medicine , disease , isoniazid , rifamycin , pediatrics , pharmacology , antibiotics , mycobacterium tuberculosis , leprosy , immunology , latent tuberculosis , pathology , microbiology and biotechnology , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom